Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease.
Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. Takahashi K, et al. Among authors: uchida m. Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2115-2126. doi: 10.2147/COPD.S268905. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32982204 Free PMC article. Clinical Trial.
Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease.
Takahashi K, Tashiro H, Tajiri R, Takamori A, Uchida M, Kato G, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. Takahashi K, et al. Among authors: uchida m. Int J Chron Obstruct Pulmon Dis. 2021 Dec 6;16:3297-3307. doi: 10.2147/COPD.S338560. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34908832 Free PMC article. Clinical Trial.
1,998 results